Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Baseline characteristics of the SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER) multidomain dementia prevention randomized controlled trial and insights from the recruitment process.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Posterior Cortical Atrophy in the Asia-Pacific: A Report From the PCA Asian Workgroup.

Annals of clinical and translational neurology·2026
Same author

ReCOGnAIze app to detect vascular cognitive impairment and mild cognitive impairment.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Cerebral haemodynamics and white matter hyperintensities: findings using non-invasive brain imaging.

The journal of prevention of Alzheimer's disease·2026
Same author

A regional framework for the detection and management of ARIA with anti-amyloid therapies in early Alzheimer's disease in Asia.

The journal of prevention of Alzheimer's disease·2026
Same author

Clinical Manifestations.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Correlates and predictors of self-efficacy among dementia caregivers: D-CARE findings.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

What should convince a clinician of disease modification in Alzheimer's disease clinical trials?

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Primary cilia-extracellular vesicle crosstalk in Alzheimer's disease: Emerging mechanisms and biomarker potential.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Timothy Aw Bang Hao1,2, Yi Jin Leow1, Nagaendran Kandiah1,3,4

  • 1Dementia Research Centre (Singapore), Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

血化tau 181 (pTau181) 可能表明执行功能,处理速度和视觉空间能力的早期认知下降. 这种微侵袭性生物标志物在显著的粉样蛋白病变之前有望检测早期阿尔茨海默病的变化.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

科学领域:

  • 神经科学是一个神经科学.
  • 生物标志物 生物标志物
  • 认知老龄化 认知老龄化

背景情况:

  • 陶氏病理驱动早期阿尔茨海默病 (AD) 的认知衰退.
  • 化 181 (pTau181) 是一种有前途的,微侵袭性的生物标志物,用于检测和粉样蛋白病理.
  • 目前的生物标志物 (PET,CSF) 具有侵入性和成本,限制了广泛使用.

研究的目的:

  • 探索血pTau181水平和非痴呆症患者的认知功能与粉样β (Aβ) 病理学下值之间的关系.
  • 评估血pTau181作为潜在的早期指标的认知缺陷在东南亚队列.

主要方法:

  • 包括来自BIOCIS研究 (新加坡) 的893名参与者,他们的Aβ值低于值 (Aβ42/40比率≥0.05).
  • 将参与者分为认知正常 (CN),主观认知衰退 (SCD) 和轻度认知障碍 (MCI) 组.
  • 使用多重回归分析来检查血pTau181与认知表现之间的关联,调整共变量.

主要成果:

  • 血pTau181升高与较差的执行功能,处理速度和视觉空间能力显著相关.
  • 血pTau181与全球认知或情节性记忆之间没有发现显著的关联.
  • 研究结果表明,血pTau181对认知功能的特异性影响.

结论:

  • 血pTau181可以作为一个微创生物标志物,用于特定领域的早期认知缺陷 (执行功能,处理速度,视觉空间能力) 在subthreshold粉样蛋白病理的个体.
  • 需要进一步的纵向研究来验证这些发现,并探索血pTau181对AD进展的预测价值.
  • 血pTau181可以整合到神经退行性疾病的早期干预策略中.